Inlyta - NDC Alphabetical Drug Index

List of NDC products with proprietary name inlyta. This medication is used to treat kidney cancer after previous treatment has not been effective. Axitinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as tyrosine kinase inhibitors.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0069-0145Inlyta AxitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-0151Inlyta AxitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
63539-026Inlyta AxitinibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug
63539-044Inlyta AxitinibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug